- Rite Aid takes a bite out of obesity; relaunches weight-loss program for New Year
- CDC's flu recommendations emphasizes convenience of retail pharmacy
- Walgreens' inoculation efforts don't go unnoticed
- Salmonella not a threat to flu vaccine production
- Tricare expands vaccination coverage to pharmacies, clinics
LEESBURG, Va. — A Virginia-based pharmacy school will collaborate with an alliance of more than 22,000 pharmacies around the country to find ways to promote and increase pneumococcal vaccinations among elderly and high-risk people.
RxAlly said it had formed a partnership with Shenandoah University's Bernard J. Dunn School of Pharmacy to collaborate on the program, funded by drug maker Pfizer. Raleigh, N.C.-based Kerr Drug, a member of RxAlly, will participate, along with pharmacy teachers, American Pharmacists Association immunization trainers, an accredited medical education company and an outcomes analytics company called RealCME. The study will focus on people 65 years and older and high-risk patients between 2 years and 64 years with co-morbid conditions. The study will be titled "Improving Patient Immunization Rates through Optimizing Pharmacy’s Role in Providing Immunization Services."
According to 2010 data from the National Health Interview Survey, pneumococcal vaccination rates among those 65 years and older was 59.7%, but 18.5% among high-risk adults ages 19 years to 64 years. In North Carolina, according to the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System, less than one-third of 10,205 patients surveyed received the vaccine.
"We couldn't be more honored and excited to work with Shenandoah University on this important public health initiative," RxAlly CEO Bruce Roberts said. "Studies show the proven value of pharmacists in increasing immunization rates, and this will continue to create awareness of how pharmacy can and does play a major role in improving health outcomes and reducing healthcare costs in our communities."
The study's objectives are to increase pneumococcal immunization rates among high-risk populations, improve the ability of pharmacists and pharmacy staff to identify candidates for receiving the pneumococcal vaccine, assist pharmacists and pharmacy staff in encouraging awareness of the importance of pneumococcal vaccine administration through direct patient interaction and work with pharmacists and pharmacy staff to increase opportunities to provide immunization-related clinical services.